By becoming authorised participants, JPMorgan and Goldman Sachs would have the ability to create and redeem shares, adding to the stability of liquid maintenance. An impressive benefit would also be the ability to align ETF share prices with each firm’s underlying assets, and, as global giants, this would benefit all parties involved. Don’t miss out…
Read more
According to Bloomberg, IHS Market information indicates short interest on BYD shares hovers around the 5.5% mark as of 1 January. Despite delivering more electric vehicles (EVs) than competitor Tesla Inc. (TSLA) in the last quarter of 2023, the put-call ratio reflects increasing cynicism in the ranks of options traders. Regarded as a forerunner in…
Read more
Reportedly, Intel did not elaborate on the value of this joint venture or its interest in it. The chipmaker did however confirm that this new organisation will have an independent board of directors, not be publicly listed, and that it is a shareholder. Earlier work in collaboration with Boston Consulting Group (BCG) laid the foundation…
Read more
The firm's ending client equity surged to $426 billion, demonstrating an impressive 39% annual growth. Financially, Interactive Brokers saw positive trends in client assets and transactions. The company reported a 14% annual increase in client margin loan balances, totalling $44.4 billion, and a 10% rise in client credit balances to $104.5 billion. Furthermore, the brokerage…
Read more
This integration allows brokers on DXtrade to leverage TradingView's extensive user base for increased visibility and direct user sign-ups. DXtrade's backend will be directly connected to the TradingView platform, simplifying the incorporation of TradingView's features for brokers who license DXtrade. This synergy centralises essential operations like order execution, risk management, and commission tracking within DXtrade,…
Read more
According to a Bloomberg report released in September of last year, BrightSpring, backed by investment management company KKR & Co. (KKR), originally hoped to garner $1bn in IPO, although this figure is now absent from the most recent filing from the US Securities and Exchange Commission on 2 January. In 2023, the healthcare provider saw…
Read more
This investment firm assisted Musk to seal the acquisition deal. Reportedly, Axios indicated a further 11% loss in value after a portfolio update for the Fidelity Blue Chip Growth Fund. X suffered a series of markdowns by Fidelity after it battled to hold onto platform advertisers. After the Twitter takeover, Musk implemented a string of…
Read more
Some prominent therapeutics were featured in the 2023-approval batch. These included Zepbound, an obesity treatment developed by Eli Lilly and Company (LLY), and Leqembi, an Alzheimer's drug from Eisai (ESAYI) and Biogen Inc. (BIIB). On top of the 55 novel drug green lights, the FDA also put its stamp of approval on five gene therapies.…
Read more
While Tesla reported producing 1.35 million cars in the first three quarters of 2023, BYD's production included battery-powered and hybrid models, predominantly in a lower price range than Tesla's solely battery-powered vehicles. Despite a slight miss in annual sales against expectations, BYD's figures reflect a significant presence in the electric vehicle market, with a diverse…
Read more
Despite uncertainty about whether bonds will ignite the same excitement as stocks, these fintechs leverage high Federal Reserve interest rates to attract retail interest. They are introducing features akin to stock trading, including low-cost options, educational tools, user-friendly apps, and fractionalised investments. Public, for instance, has begun allowing customers to invest in smaller portions of…
Read more